Bioequivalence of GomcillinTM Capsule to FamoxinTM Capsule (Amoxicillin 500 mg) |
Lee, Yun-Young
(Department of Drug Development Service, BioCore Co., Ltd.)
Choi, Mee-Hee (Department of Drug Development Service, BioCore Co., Ltd.) Lee, Kyung-Ryul (Department of Pharmacokinetics, Seoul Medical Science Institute, Seoul Clinical Laboratories, Department of Drug Development Service, BioCore Co., Ltd.) Lee, Hee-Joo (Department of Pharmacokinetics, Seoul Medical Science Institute, Seoul Clinical Laboratories, Department of Drug Development Service, BioCore Co., Ltd.) |
1 | American Society of Health-System Pharmacists, Amoxi-cillin. AHFS Drug Information, 380-382 (2001) |
2 | L.R. Pires de Abreu, RM. Ortiz, S.C. de Castro and J.Jr. Pedrazzoli, HPLC determination of amoxicillin comparative bioavailability in healthy volunteers after a single dose administration. J. Pharm. Pharm. Sci., 6, 223-230 (2003) |
3 | D. Zarowny, R Ogilvie, D. Tamblyn, C. MacLeod and J.Ruedy, Pharmacokinetics of amoxicillin. Clin. Pharmacol. Ther., 16, 1045-1051 (1974) DOI |
4 | G.A. Digenis, E.P. Sandefer, R.C. Page, W.J. Doll, T.B. Gold and N.B. Darwazeh, Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture. Pharm. Res., 17, 572-582 (2000) DOI ScienceOn |
5 | 식품의약품안전청 고시 제 2002-60호, 생물학적동등성시험기준 (2002. 11. 22) |
6 | Y.J. Lee, Y.G. Kim, M.G. Lee, S.J. Chung, M.H. Lee and C.K. Shim, Analysis of bioequivalence study using log-transformed model. Yakhakhoeji, 44, 308-314 (2000) |
7 | 식품의약품안전청 고시 재 2002-61호, 의약품동등성시험관리규정 (2002. 11. 22) |
8 | M. Kidwai, P. Sapra and K.R Bhushan, Synthetic strategies and medical properties of beta-lactams. Curr Med. Chern., 6, 195-215 (1999) |